Direkt zum Inhalt
Merck

Structural and functional analysis of fucose-processing enzymes from Streptococcus pneumoniae.

Journal of molecular biology (2013-12-18)
Melanie A Higgins, Michael D Suits, Candace Marsters, Alisdair B Boraston
ZUSAMMENFASSUNG

Fucose metabolism pathways are present in many bacterial species and typically contain the central fucose-processing enzymes fucose isomerase (FcsI), fuculose kinase (FcsK), and fuculose-1-phosphate aldolase (FcsA). Fucose initially undergoes isomerization by FcsI producing fuculose, which is then phosphorylated by FcsK. FcsA cleaves the fuculose-1-phosphate product into lactaldehyde and dihydroxyacetone phosphate, which can be incorporated into central metabolism allowing the bacterium to use fucose as an energy source. Streptococcus pneumoniae has fucose-processing operons containing homologs of FcsI, FcsK, and FcsA; however, this bacterium appears unable to utilize fucose as an energy source. To investigate this contradiction, we performed biochemical and structural studies of the S. pneumoniae fucose-processing enzymes SpFcsI, SpFcsK, and SpFcsA. These enzymes are demonstrated to act in a sequential manner to ultimately produce dihydroxyacetone phosphate and have structural features entirely consistent with their observed biochemical activities. Analogous to the regulation of the Escherichia coli fucose utilization operon, fuculose-1-phosphate appears to act as an inducing molecule for activation of the S. pneumoniae fucose operon. Despite our evidence that S. pneumoniae appears to have the appropriate regulatory and biochemical machinery for fucose metabolism, we confirmed the inability of the S. pneumoniae TIGR4 strain to grow on fucose or on the H-disaccharide, which is the probable substrate of the transporter for the pathway. On the basis of these observations, we postulate that the S. pneumoniae fucose-processing pathway has a non-metabolic role in the interaction of this bacterium with its human host.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Tetramethylammoniumhydroxid Pentahydrat, ≥97%
Sigma-Aldrich
Tetramethylammoniumchlorid -Lösung, Molecular Biology
Sigma-Aldrich
Tetramethylammoniumhydroxid Pentahydrat, ≥95.0% (T)
Sigma-Aldrich
Tetramethylammoniumchlorid, reagent grade, ≥98%
Sigma-Aldrich
Azithromycin
Sigma-Aldrich
Tetramethylammoniumfluorid, 97%
Sigma-Aldrich
Aldolase aus Kaninchenmuskel, lyophilized powder, ≥8.0 units/mg protein
Sigma-Aldrich
Tetramethylammoniumiodid, 99%
Supelco
Tetramethylammoniumchlorid, suitable for ion pair chromatography, LiChropur, ≥99.0% (AT)
Sigma-Aldrich
Tetramethylammoniumchlorid, BioUltra, Molecular Biology, ≥99.0% (AT)
Sigma-Aldrich
Aldolase aus Kaninchenmuskel, ammonium sulfate suspension, 10-20 units/mg protein
Azithromycin für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Azithromycin für die Preakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Azithromycin, European Pharmacopoeia (EP) Reference Standard
USP
Azithromycin-Identität, United States Pharmacopeia (USP) Reference Standard
Supelco
Tetramethylammoniumsulfat, suitable for ion pair chromatography, LiChropur, ≥99.0% (T)